ADA 2020: Decreasing Risk of Heart Failure Hospitalization With Empagliflozin
June 23rd 2020Findings of a recent study suggest empagliflozin is associated with a decreased risk of hospitalization for heart failure and a similar risk of myocardial infarction or stroke in routine clinical care.
Read More